Clinical Trial Update: Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating plasma exchange with 5% human serum albumin for acute-on-chronic liver failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Human serum albumin 5% (human serum albumin)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Acute-On-Chronic Liver Failure | Phase 3 | Status: TERMINATED